The global inhaled nitric oxide delivery systems market value was US$ 247.5 million in 2020. The global inhaled nitric oxide delivery systems market value is forecast to reach US$ 496 million by 2030, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2021-2030.
A delivery system for inhaled nitric oxide aids in relaxing smooth muscle, resulting in widening (dilating) blood vessels, specifically in the lungs, that assimilate through a diverse range of conditions. Inhalation of nitric oxide sometimes serves to treat chronic respiratory diseases and treat infants with severe breathing problems associated with narrow blood vessels in the lungs.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global inhaled nitric oxide delivery systems market. Due to nitric oxide's antiviral properties and increased oxygenation, researchers tested it as an alternative treatment for COVID-19. Additionally, it helps protect healthcare workers on the front line from getting ill from the pandemic. In addition, nitric oxide inhaled in COVID-19 was evaluated in several randomized clinical trials to treat pulmonary hypertension, Acute respiratory distress syndrome (ARDS), and other respiratory diseases. Additionally, inhaled nitric oxide is currently undergoing multiple clinical trials as a treatment for COVID-19, with promising results in clinical trials.
Regional Insights
During the forecast period, North America is forecast to register the fastest CAGR. The growth is mainly due to the rising rates of neonatal mortality caused by the epidemic of HRF. A rise in INO therapy adoption, favorable government policies, and the presence of advanced medical infrastructure all contribute to regional growth.
During the forecast period, Asia Pacific will have the largest revenue share due to the growing pediatric population, an increase in respiratory failure patients, and the presence of local manufacturers of nitric oxide disposables & systems.
Leading Competitors
The leading prominent companies profiled in the global inhaled nitric oxide delivery system market are:
Scope of the Report
The global inhaled nitric oxide delivery system market segmentation focuses on Type, Application, Product, End-user, and Region.
Segmentation based on Type
Segmentation based on Application
Segmentation based on End-user
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, BY TYPE
5.1 OVERVIEW
5.2 PEDIATRICS
5.3 ADULT
6 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 NEONATAL RESPIRATORY TREATMENT
6.3 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
6.4 MALARIA TREATMENT
6.5 TUBERCULOSIS TREATMENT
6.6 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
6.7 CHRONIC WOUND HEALING
6.8 OTHERS
7 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 AMBULATORY CENTERS
7.4 CLINICS
8 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 AIR LIQUIDE HEALTHCARE
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BELLEROPHON THERAPEUTICS
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 BEYOND AIR
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 CIRCASSIA PHARMACEUTICALS
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 GETINGE
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 LINDE
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 MALLINCKRODT PHARMACEUTICALS
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8. NU MED
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 SLE
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 VERO BIOTECH
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved